Finance

Lists
507789:BOM
Jagsonpal Pharmaceuticals Ltd
₹219,00
-0,25%
(-0,55) 1D
16 Okt., 15:52:30 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 507789...
Open
₹219,55
High
₹222,95
Low
₹216,85
Mkt. cap
14,45 mjd
Avg. vol.
19,68 k
Volume
1,65 k
Dividend
1,14%
Quarterly dividend
₹0,63
Ex-dividend date
04 Sep. 2026
P/E ratio
32,52
52-wk high
₹264,65
52-wk low
₹154,90
EPS
₹6,73
Shares outstanding
26,20 m
No. of employees
1 k
Open
₹219,55
High
₹222,95
Low
₹216,85
Mkt. cap
14,45 mjd
Avg. vol.
19,68 k
Volume
1,65 k
Dividend
1,14%
Quarterly dividend
₹0,63
Ex-dividend date
04 Sep. 2026
P/E ratio
32,52
52-wk high
₹264,65
52-wk low
₹154,90
EPS
₹6,73
Shares outstanding
26,20 m
No. of employees
1 k
News stories
From web sources and news partners
About Jagsonpal Pharmaceuticals Ltd
CEO-
Employees1,3 k
Founded1978
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
744,65 m
729,45 m
642,03 m
822,32 m
Cost of goods sold
272,28 m
264,53 m
249,67 m
286,24 m
Cost of revenue
272,28 m
264,53 m
249,67 m
286,24 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
165,46 m
172,95 m
397,81 m
227,78 m
Operating expense
331,89 m
326,10 m
303,96 m
385,10 m
Total operating expenses
604,17 m
590,63 m
553,63 m
671,34 m
Operating income
140,48 m
138,82 m
88,40 m
150,98 m
Other non operating income
30,27 m
29,75 m
-87,71 m
28,33 m
EBT including unusual items
168,10 m
145,21 m
117,56 m
176,80 m
EBT excluding unusual items
168,10 m
166,00 m
117,56 m
176,80 m
Income tax expense
42,36 m
35,70 m
29,94 m
44,91 m
Effective tax rate
25,20%
24,59%
25,47%
25,40%
Other operating expenses
126,28 m
126,45 m
-82,94 m
135,90 m
Net income
125,74 m
109,51 m
87,62 m
131,89 m
Net profit margin
16,89%
15,01%
13,65%
16,04%
Earnings per share
-
-
-
-
Interest and investment income
-
-
117,43 m
-
Interest expense
-2,65 m
-2,57 m
-560,00 k
-2,51 m
Net interest expenses
-2,65 m
-2,57 m
116,87 m
-2,51 m
Depreciation and amortization charges
23,86 m
23,86 m
23,19 m
21,42 m
EBITDA
164,18 m
155,55 m
108,00 m
174,59 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme